Study of BBP-418 in Patients With LGMD2I | MicrobiomeTrials← Back to trialsNCT04800874
Study of BBP-418 in Patients With LGMD2I
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-02-18Est. Completion: 2026-11-01
Enrollment target: 14 participants Locations- Virginia Commonwealth University, Richmond, Virginia, United States
Other microbiome trials you might be interested in
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
This is an open-label extension (rollover) study designed to evaluate the long-term safety and efficacy of BBP-418 (ribi…
Little Rock, United StatesEst. completion Oct 2030
Limb Girdle Muscular DystrophyLimb-Girdle Muscular Dystrophy Type 2LGMD2IMuscular DystrophyLGMD2LGMDFKRPFKRP Mutation
Fukutin Related Protein
The purpose of this study is to evaluate the safety and tolerability of a single intravenous infusion of AB-1003 in adul…
Irvine, United StatesEst. completion Dec 2028